Disclosure: A. Iwase, Otsuka (R), Carl Zeiss Meditec (R), Topcon (R), Santen (R), Pfizer (R), Senjyu (R), Kowa (R), P; A. Sekine, Topcon (E), P; J. Suehiro, Topcon (E); K. Tanaka, None; Y. Kawasaki, Senjyu (F), Novartis (F), Japan Health Research Institute (F), Pfizer Japan (F), Rohto (F); R. Kawasaki, Santen (R), Senjyu (F, R), Novartis (F, R), Bayer (F), Japan Health Research Institute (F), Pfizer Japan (F, R), Rohto (F), Predictive Analytics Group Future, Inc. (C), Office Future, Inc. (C), Kowa (R), Bayer (R), Takeda (R), Novo Nordisk (R), Astellas (R); M.J. Sinai, Topcon (E); M. Araie, B&M (C), Senjyu (C), Santen (C), Kowa (C),Pfizer, (C), Topcon (C), Allergan (C), Alcon (C), Heidelberg Engineering (C), Aerie (C), Nitten (R), Otsuka (R), Carl Zeiss Meditec (R), P